2016
DOI: 10.1016/j.jclinane.2015.12.010
|View full text |Cite
|
Sign up to set email alerts
|

Anesthetic management of an ex utero intrapartum treatment procedure: a novel balanced approach

Abstract: Ex utero intrapartum treatment (EXIT) procedures are therapeutic interventions for fetuses with life-threatening airway abnormalities and/or other prenatally diagnosed congenital malformations requiring immediate neonatal extracorporeal membrane oxygenation support. Although certain anesthetic goals are common among EXIT procedures, many different approaches to their management have been described in the literature. Herein, we present a novel anesthetic approach to an EXIT procedure for fetal micrognathia and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
19
0
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 93 publications
(20 citation statements)
references
References 12 publications
0
19
0
1
Order By: Relevance
“…However, there remains potential for fetal complications related to the inability to secure the airway at the time of the EXIT procedure due to placental separation/abruption or fetal bradycardia from cord compression [6]. Furthermore, the potential advantage to the fetus must be weighed against increased maternal risks, including longer operating times, maternal hypotension requiring vasopressor support, pulmonary edema secondary to fluid overload, and postpartum hemorrhage from uterine atony induced by high concentrations of inhalational agents, and wound infections [3,6,8,9].…”
Section: Discussionmentioning
confidence: 99%
“…However, there remains potential for fetal complications related to the inability to secure the airway at the time of the EXIT procedure due to placental separation/abruption or fetal bradycardia from cord compression [6]. Furthermore, the potential advantage to the fetus must be weighed against increased maternal risks, including longer operating times, maternal hypotension requiring vasopressor support, pulmonary edema secondary to fluid overload, and postpartum hemorrhage from uterine atony induced by high concentrations of inhalational agents, and wound infections [3,6,8,9].…”
Section: Discussionmentioning
confidence: 99%
“…Epidural was used in some cases as a form of post-operative pain relief 12,15 . General anaesthetic allows for the use of inhalation agents which cause tocolysis, described by Braden et al 2 as complete uterine relaxation. Tocolysis prevents placental separation, therefore is essential for the success of the EXIT procedure and, in turn, survival of the fetus 12 .…”
Section: The Proceduresmentioning
confidence: 99%
“…In addition to inhalational agents such as desflurane 2, 12 sevoflurane 1 and isoflurane 15 , nitroglycerine was reported by multiple authors as being used to maintain tocolysis 2,8,11,12 . Tocolytic agents may cause maternal hypotension, which in turn may interfere with the maintenance of placental circulation and fetal oxygenation 8 .…”
Section: The Proceduresmentioning
confidence: 99%
See 1 more Smart Citation
“…[13] With maintenance of fetal oxygenation via uteroplacental circulation, sufficient time is provided to achieve airway access in a fetus through direct laryngoscopy, fiberoptic bronchoscopy, or tracheostomy. [47] However, it is very challenging to establish airway access during the EXIT procedure, even for anesthesiologists who are very skilled at airway management, because such a fetus has severe airway difficulty that necessitates the EXIT procedure and there is insufficient room for airway management within the surgical field.…”
Section: Introductionmentioning
confidence: 99%